The upregulation of miR-483-5p was also associated with poorer disease-specific survival in patients with adrenocortical carcinomas [31], and the expression of miR-483-5p promotes HCC cell proliferation by targeting the suppressor of cytokine signaling 3 (Socs3) [32]. This evidence concerns the gene SOCS3 and hepatocellular carcinoma.